Lubrizol Announces an Important Milestone for Its Novel Patented Excipient, Apisolex™ Polymer
CLEVELAND, June 09, 2025--(BUSINESS WIRE)--Lubrizol announces that an Apisolex™ polymer excipient-enabled drug formulation is in Phase 1 clinical trials.
Introduced to the market in 2022, Apisolex polymer excipient is a polyamino acid-based polymer that enhances the solubility of BCS Class II and IV active pharmaceutical ingredients (API). Apisolex polymer excipient is manufactured following Good Manufacturing Practices (GMP) guidelines and can be used in dosage forms for various routes of administration, including parenteral.
The use of Apisolex polymer excipient has been proven to increase the solubility of certain APIs by as much as 50,000-fold. Apisolex polymer excipient is currently being evaluated in multiple programs across the globe, enabling delivery of hard-to-formulate APIs from various therapeutic classes and by multiple routes.
Kevin Song, Senior Director, Global Pharmaceutical and Nutraceutical Business, notes "the progression to clinical trials of a medicinal product formulated with Apisolex polymer excipient demonstrates its ability to provide differentiated solutions to solubility and bioavailability challenges in parenteral formulations." Song adds, "Lubrizol continues to invest in expanding the reach of the Apisolex polymer excipient across global markets and nurturing relationships with drug product manufacturers that are facing insoluble API challenges."
About Lubrizol
Lubrizol, a Berkshire Hathaway company, is a science-based company whose specialty chemistry delivers sustainable solutions to advance mobility, improve well-being and enhance modern life. Every day, the innovators of Lubrizol strive to create extraordinary value for customers at the intersection of science, market needs and business success, driving discovery and creating breakthrough solutions that enhance life and make the world work better. Founded in 1928, Lubrizol has global reach and local presence, with over 100 manufacturing facilities, sales and technical offices and over 7,000 employees worldwide. For more information, visit www.lubrizol.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250609920110/en/
Contacts
MEDIA CONTACT Lori Ditty, Global Marketing ManagerLori.Ditty@Lubrizol.com Lubrizol.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
21 minutes ago
- Yahoo
KBRA Assigns Preliminary Ratings to Progress Residential 2025-SFR3
NEW YORK, June 09, 2025--(BUSINESS WIRE)--KBRA assigns preliminary ratings to eight classes of Progress Residential 2025-SFR3 (Progress 2025-SFR3) single family rental (SFR) pass-through certificates. Progress 2025-SFR3 is the first ever single-borrower, SFR securitization consisting entirely of Build-to-Rent (BTR) communities. The transaction will be collateralized by a $778.5 million five-year fixed-rate interest-only loan secured by mortgages on 2,020 income-producing single-family homes. All of the homes are located in 21 newly built, amenity-light BTR communities that were purchased by the sponsor between June 2023 and May 2024 from the original builder. The properties serving as collateral comprise 100% of the homes in 20 communities and 51% of the homes in the remaining community, with each home on an individual tax parcel. The subject transaction will be the 31st KBRA-rated SFR securitization issued by Progress Residential. The communities are located in 18 Core Based Statistical Areas (CBSAs) across 10 states. The top three CBSAs represent 34.0% of the portfolio and include Lakeland-Winter Haven (13.1%), Sacramento (10.8%), and Atlanta (10.2%). The single largest community accounts for 10.8% of the collateral portfolio and the top three communities account for 30.0% of the portfolio. The aggregate BPO value of the underlying homes is $782.4 million, yielding an LTV of 99.5%. KBRA adjusted the BPOs, which yielded an aggregate value of $751.1 million, which represents a 4.0% haircut to the nominal BPO value. The resulting LTV based on KBRA's adjusted BPO value was 103.6%. KBRA uses a hybrid analysis to evaluate SFR transactions, which incorporates elements of both KBRA's CMBS and RMBS methodologies, as the underlying real estate contains commercial and residential characteristics. As the properties generate a cash flow stream from tenant rental payments, elements of CMBS methodologies are used to determine the loan's probability of default (PD). To determine loss given default (LGD), KBRA assumes the underlying properties would be liquidated in the residential property market. In determining LGD, KBRA subjects the real estate properties to home price stress scenarios using elements of RMBS methodologies. This hybrid analysis is described in more in KBRA's U.S. Single-Family Rental Securitization Methodology. To access ratings and relevant documents, click here. Click here to view the report. Methodologies CMBS/RMBS: U.S. Single-Family Rental Securitization Methodology Structured Finance: Global Structured Finance Counterparty Methodology ESG Global Rating Methodology Disclosures Further information on key credit considerations, sensitivity analyses that consider what factors can affect these credit ratings and how they could lead to an upgrade or a downgrade, and ESG factors (where they are a key driver behind the change to the credit rating or rating outlook) can be found in the full rating report referenced above. A description of all substantially material sources that were used to prepare the credit rating and information on the methodology(ies) (inclusive of any material models and sensitivity analyses of the relevant key rating assumptions, as applicable) used in determining the credit rating is available in the Information Disclosure Form(s) located here. Information on the meaning of each rating category can be located here. Further disclosures relating to this rating action are available in the Information Disclosure Form(s) referenced above. Additional information regarding KBRA policies, methodologies, rating scales and disclosures are available at About KBRA Kroll Bond Rating Agency, LLC (KBRA), one of the major credit rating agencies (CRA), is a full-service CRA registered with the U.S. Securities and Exchange Commission as an NRSRO. Kroll Bond Rating Agency Europe Limited is registered as a CRA with the European Securities and Markets Authority. Kroll Bond Rating Agency UK Limited is registered as a CRA with the UK Financial Conduct Authority. In addition, KBRA is designated as a Designated Rating Organization (DRO) by the Ontario Securities Commission for issuers of asset-backed securities to file a short form prospectus or shelf prospectus. KBRA is also recognized as a Qualified Rating Agency by Taiwan's Financial Supervisory Commission and is recognized by the National Association of Insurance Commissioners as a Credit Rating Provider (CRP) in the U.S. Doc ID: 1009753 View source version on Contacts Analytical Contacts Maulik Pareliya, Associate (Lead Analyst)+1 Fred Perreten, Managing Director+1 Akshay Maheshwari, Managing Director+1 Nitin Bhasin, Senior Managing Director, Global Head of CMBS (Rating Committee Chair)+1 Business Development Contact Andrew Foster, Director+1
Yahoo
22 minutes ago
- Yahoo
Argan, Inc. to Announce First Quarter Fiscal 2026 Results and Host Conference Call on Wednesday, June 4, 2025
ARLINGTON, Va., May 21, 2025--(BUSINESS WIRE)--Argan, Inc. (NYSE: AGX) ("Argan" or the "Company") today announced that the Company will release its first quarter 2026 financial results after the market closes on Wednesday, June 4, 2025. Management will host a webcast with an accompanying slide presentation and conference call on Wednesday, June 4, 2025 at 5:00 p.m. ET. Participants can access the live webcast by visiting this link. To access the call by phone, participants can use the following dial-in information: Domestic: 888-506-0062 International: 973-528-0011 Access code: 698123 A replay of the teleconference will be available until June 18, 2025, and can be accessed by dialing 877-481-4010 (domestic) or 919-882-2331 (international). The replay access code is 52474. A replay of the webcast can be accessed until June 4, 2026. About Argan Argan's primary business is providing a full range of construction and related services to the power industry. Argan's service offerings focus on the engineering, procurement and construction of natural gas-fired power plants and renewable energy facilities, along with related commissioning, maintenance, project development and technical consulting services, through its Gemma Power Systems and Atlantic Projects Company operations. Argan also owns The Roberts Company, which is a fully integrated industrial construction, fabrication and plant services company, and SMC Infrastructure Solutions, which provides telecommunications infrastructure services. View source version on Contacts Company Contact: David Watson301.315.0027 Investor Relations: John Nesbett/Jennifer BelodeauIMS Investor Relations203.972.9200argan@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
25 minutes ago
- Yahoo
MochaLean Announces Official Website Update Featuring Natural Daily Supplement for Weight Management Support
New U.S.-Available Metabolism Support Supplement Designed to Promote Appetite Control and Daily Energy Balance Naturally TALLMADGE, June 09, 2025 (GLOBE NEWSWIRE) -- MochaLean™, a U.S.-based wellness brand, has updated its official website to share new information about its daily supplement developed to support healthy weight management in adults. Now available in the U.S., the plant-based formula is designed for individuals seeking a natural, routine-friendly wellness solution. According to the official product website ( MochaLean™ is intended to work in harmony with the body's internal systems to support metabolism, appetite regulation, and energy levels. The company positions the supplement as a convenient, daily-use formula that integrates into everyday life without requiring restrictive diets or complicated routines. 'We believe health support should be simple and natural,' said a company spokesperson. 'This product reflects our commitment to natural wellness and quality-driven formulation.' The company states that MochaLean™ is manufactured in facilities that follow strict safety and quality control protocols. The formulation is composed of ingredients selected to align with common adult wellness goals, such as metabolic support, healthy energy maintenance, and appetite balance. As noted on the product website, MochaLean™ includes a satisfaction guarantee for new customers. Those interested in exploring the formula's intended uses or ordering directly can find full details, FAQs, and purchasing options at the official site. About MochaLean™ MochaLean™ is a U.S.-based wellness brand focused on delivering natural, easy-to-use supplements that support daily health routines. Committed to transparency and simplicity, the company aims to provide effective solutions that help adults feel their best. Product and Contact Information Brand: MochaLean™Website: support@ 1-800-390-6035Return Address: Fulfillment House, 285 Northeast Ave, Tallmadge, OH 44278, USA Disclaimer This release is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. The statements made about this product have not been evaluated by the Food and Drug Administration. Individual results may vary. Consumers should consult a qualified healthcare provider before beginning any new dietary supplement. CONTACT: Email: support@ Phone: 1-800-390-6035 Return Address: Fulfillment House, 285 Northeast Ave, Tallmadge, OH 44278, USA
